Marker Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $19.06 million, with shareholders equity totaling $12.17 million.
The company employs approximately 8 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Marker Therapeutics Inc. reported $2.34 million in revenue, generating net income of $-8.71 million.
Key financial metrics include a P/E ratio of -2.19, a price-to-book (P/B) ratio of 1.57, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker MRKR.